Target: ₹1,650
CMP: ₹1,712.75
ICICI Lombard General Insurance is well on track to achieve 102 per cent combined operating ratio (CoR) by FY25; its shares have run up sharply post good Q3FY24 results.
Recent outperformance of ICICI Lombard shares appears to be fully pricing-in improved operational performance and optimism of: no near-term headwind for GI on the Regulatory front; minimum 0.8 per cent stake purchase by ICICI Bank before 9-Sep-24; material improvement in CoR and EPS on Ind-AS implementation starting Apr-25.
But we also see challenges: likelihood of no hike in Motor TP tariffs causing lower industry growth and worsening of combined ratio in the TP segment; prospect of greater intensity in Motor OD and Retail Health to drive higher distribution payouts and pressure on pricing, in pursuit of growth by smaller players; price revision-led growth moderating in the Health segment.
Against this backdrop, we marginally revise our FY24-26 estimates, leading to 1-2 per cent cut in GWP, about 0.4 percentage point increase in CoR and about 3-4 per cent cut in EPS for FY25-26. We downgrade the stock to Reduce from Add, with Mar-25E TP of ₹1,650 (vs. Dec-24E TP of ₹1,600 earlier), implying 28x FY26E P/E and 5.2x FY26E P/B.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.